Literature DB >> 33605225

Cochlear Implantation Outcomes in Patients with Mitochondrial Hearing Loss: A Systematic Review and Narrative Synthesis.

Nawal Zia1, Yasmin Nikookam1, Jameel Muzaffar2, Peter Kullar3, Peter Monksfield1, Manohar Bance3.   

Abstract

This study's aim was to establish outcomes following cochlear implantation (CI) in patients with mitochondrial disorders associated with deafness. Systematic review and narrative synthesis. Databases searched: Medline, EMBASE, Web of Science, COCHRANE, and ClinicalTrials.gov. No limits on language or year of publication. Review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Searches identified 437 abstracts and 37 full text articles, of which 11 studies met the inclusion criteria reporting outcomes in a total of 17 patients. All implants achieved good hearing outcomes, and follow-up ranged between 1 week and 12 months. The methodological quality of the included studies was sufficient, scoring grades 3 to 4 using the Oxford Centre for Evidence Based Medicine grading system. All studies were retrospective and consisted of case reviews and case reports. All cases of CI showed positive outcomes in speech perception and detection. There is some qualitative evidence to suggest improvement in quality of life and satisfaction postoperatively. There was very limited information available on secondary outcomes such as surgical complications, quality of life, and method of cochlear implant insertion. The small sample size of our patient cohort and quality of studies suggests a need for large-scale studies with more robust methodology to assess the effectiveness of CI. There is a need for studies that assess other factors to be considered when counseling patients about cochlear implants, such as adverse events, surgical complications, and long-term benefits.

Entities:  

Year:  2021        PMID: 33605225      PMCID: PMC7901420          DOI: 10.5152/iao.2020.9226

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  18 in total

1.  Cochlear implantation in maternal inherited diabetes and deafness syndrome.

Authors:  V Raut; A R Sinnathuray; J G Toner
Journal:  J Laryngol Otol       Date:  2002-05       Impact factor: 1.469

Review 2.  The epidemiology of mitochondrial disorders--past, present and future.

Authors:  Andrew M Schaefer; Robert W Taylor; Douglass M Turnbull; Patrick F Chinnery
Journal:  Biochim Biophys Acta       Date:  2004-12-06

3.  Role of mitochondrial variation in maternally inherited diabetes and deafness syndrome.

Authors:  T Howes; C Madden; S Dasgupta; S Saeed; V Das
Journal:  J Laryngol Otol       Date:  2008-11       Impact factor: 1.469

4.  Maternally inherited diabetes and deafness: prevalence in a hospital diabetic population.

Authors:  J E Newkirk; R W Taylor; N Howell; L A Bindoff; P F Chinnery; K G Alberti; D M Turnbull; M Walker
Journal:  Diabet Med       Date:  1997-06       Impact factor: 4.359

5.  Successful cochlear implantation in a patient with mitochondrial hearing loss and m.625G>A transition.

Authors:  A Sudo; N Takeichi; K Hosoki; S Saitoh
Journal:  J Laryngol Otol       Date:  2011-09-14       Impact factor: 1.469

Review 6.  Cochlear implantation of a patient with a previously undescribed mitochondrial DNA defect.

Authors:  P R Counter; M P Hilton; D Webster; T Wardell; R W Taylor; G Besley; D M Turnbull; P J Robinson
Journal:  J Laryngol Otol       Date:  2001-09       Impact factor: 1.469

7.  Cochlear implantation in a patient with profound hearing loss with the A1555G mitochondrial DNA mutation and no history of aminoglycoside exposure.

Authors:  S Arif Ulubil; Alexis D Furze; Simon I Angeli
Journal:  J Laryngol Otol       Date:  2005-11-25       Impact factor: 1.469

Review 8.  Mitochondrial deafness.

Authors:  H Kokotas; M B Petersen; P J Willems
Journal:  Clin Genet       Date:  2007-05       Impact factor: 4.438

9.  A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation.

Authors:  M Mancuso; M Filosto; F Forli; A Rocchi; S Berrettini; G Siciliano; L Murri
Journal:  Acta Neurol Scand       Date:  2004-07       Impact factor: 3.209

Review 10.  Treatment for mitochondrial disorders.

Authors:  Gerald Pfeffer; Kari Majamaa; Douglass M Turnbull; David Thorburn; Patrick F Chinnery
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
View more
  3 in total

1.  Cochlear Implantation in Patients with Mitochondrial Gene Mutation: Decline in Speech Perception in Retrospective Long-Term Follow-Up Study.

Authors:  Kai Kanemoto; Akinori Kashio; Erika Ogata; Yusuke Akamatsu; Hajime Koyama; Tsukasa Uranaka; Yujiro Hoshi; Shinichi Iwasaki; Tatsuya Yamasoba
Journal:  Life (Basel)       Date:  2022-03-26

2.  Endocrine Manifestations and New Developments in Mitochondrial Disease.

Authors:  Yi Shiau Ng; Albert Zishen Lim; Grigorios Panagiotou; Doug M Turnbull; Mark Walker
Journal:  Endocr Rev       Date:  2022-05-12       Impact factor: 25.261

3.  Effects of CoQ10 Replacement Therapy on the Audiological Characteristics of Pediatric Patients with COQ6 Variants.

Authors:  Dong Woo Nam; Sang Soo Park; So Min Lee; Myung-Whan Suh; Moo Kyun Park; Jae-Jin Song; Byung Yoon Choi; Jun Ho Lee; Seung Ha Oh; Kyung Chul Moon; Yo Han Ahn; Hee Gyung Kang; Hae Il Cheong; Ji Hyun Kim; Sang-Yeon Lee
Journal:  Biomed Res Int       Date:  2022-09-09       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.